These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20863722)

  • 1. Paraffin-embedded tissue is less accurate than frozen section analysis for determining VHL mutational status in sporadic renal cell carcinoma.
    Verhoest G; Patard JJ; Fergelot P; Jouan F; Zerrouki S; Dreano S; Mottier S; Rioux-Leclercq N; Denis MG
    Urol Oncol; 2012; 30(4):469-75. PubMed ID: 20863722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.
    Zhuang Z; Gnarra JR; Dudley CF; Zbar B; Linehan WM; Lubensky IA
    Mod Pathol; 1996 Aug; 9(8):838-42. PubMed ID: 8871925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequencing of the von Hippel-Lindau gene in canine renal carcinoma.
    Pressler BM; Williams LE; Ramos-Vara JA; Anderson KI
    J Vet Intern Med; 2009; 23(3):592-7. PubMed ID: 19422471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study.
    van Houwelingen KP; van Dijk BA; Hulsbergen-van de Kaa CA; Schouten LJ; Gorissen HJ; Schalken JA; van den Brandt PA; Oosterwijk E
    BMC Cancer; 2005 Jun; 5():57. PubMed ID: 15932632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
    Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma.
    Kim JH; Jung CW; Cho YH; Lee J; Lee SH; Kim HY; Park J; Park JO; Kim K; Kim WS; Park YS; Im YH; Kang WK; Park K
    Oncol Rep; 2005 May; 13(5):859-64. PubMed ID: 15809750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VHL protein alterations in sporadic renal cell carcinoma.
    Giménez-Bachs JM; Salinas-Sánchez AS; Sánchez-Sánchez F; Lorenzo-Romero JG; Donate-Moreno MJ; Pastor-Navarro H; Carrión-López P; Escribano-Martínez J; Virseda-Rodríguez JA
    Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):784-9. PubMed ID: 17919893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity.
    Trotta AM; Santagata S; Zanotta S; D'Alterio C; Napolitano M; Rea G; Camerlingo R; Esposito F; Lamantia E; Anniciello A; Botti G; Longo N; Botti G; Pignata S; Perdonà S; Scala S
    J Exp Clin Cancer Res; 2018 Dec; 37(1):297. PubMed ID: 30514329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of biallelic inactivation of the von Hippel-Lindau tumor suppressor gene VHL in patients of renal cell carcinoma patient].
    Liu N; Gong K; Zhang N; Guo HF; Na X; Wu G; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(2):115-7. PubMed ID: 15771820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
    Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
    Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC.
    Gallou C; Joly D; Méjean A; Staroz F; Martin N; Tarlet G; Orfanelli MT; Bouvier R; Droz D; Chrétien Y; Maréchal JM; Richard S; Junien C; Béroud C
    Hum Mutat; 1999; 13(6):464-75. PubMed ID: 10408776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol consumption and mutations or promoter hypermethylation of the von Hippel-Lindau gene in renal cell carcinoma.
    Schouten LJ; van Dijk BA; Oosterwijk E; van Engeland M; Hulsbergen-van de Kaa CA; Kiemeney LA; Goldbohm RA; Kester A; de Vogel S; Schalken JA; van den Brandt PA
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3543-50. PubMed ID: 19064569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique molecular alteration patterns in von Hippel-Lindau (VHL) gene in a cohort of sporadic renal cell carcinoma patients from Pakistan.
    Khaliq S; Ajaz S; Firasat S; Shahid S; Hasan AS; Sultan G; Mohsin R; Hashmi A; Mubarak M; Naqvi SA; Rizvi SA; Mehdi SQ; Abid A
    Mutat Res; 2014; 763-764():45-52. PubMed ID: 24727139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutational analysis of the vhl gene in the sporadic renal cell carcinoma].
    Giménez Bachs JM; Salinas Sánchez A; Lorenzo Romero J; Sánchez Sánchez F; Donate Moreno MJ; García Olmo D; Escribano Martínez J; Virseda Rodríguez J
    Arch Esp Urol; 2004 Sep; 57(7):671-7. PubMed ID: 15536948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole genome and transcriptome amplification: practicable tools for sustainable tissue biobanking?
    von Teichman A; Storz M; Dettwiler S; Moch H; Schraml P
    Virchows Arch; 2012 Nov; 461(5):571-80. PubMed ID: 23007645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma.
    Brauch H; Weirich G; Hornauer MA; Störkel S; Wöhl T; Brüning T
    J Natl Cancer Inst; 1999 May; 91(10):854-61. PubMed ID: 10340905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma.
    Patard JJ; Fergelot P; Karakiewicz PI; Klatte T; Trinh QD; Rioux-Leclercq N; Said JW; Belldegrun AS; Pantuck AJ
    Int J Cancer; 2008 Jul; 123(2):395-400. PubMed ID: 18464292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Hippel-Lindau exonic methylation analysis using MALDI-TOF mass spectrometry.
    Lian F; Sreedharan S; Arnold RS; Master VA; Ogan K; Pattaras JG; Roberts DL; Petros JA
    J Urol; 2014 Nov; 192(5):1528-33. PubMed ID: 24704013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and epigenetic alterations in the von hippel-lindau gene: the influence on renal cancer prognosis.
    Smits KM; Schouten LJ; van Dijk BA; Hulsbergen-van de Kaa CA; Wouters KA; Oosterwijk E; van Engeland M; van den Brandt PA
    Clin Cancer Res; 2008 Feb; 14(3):782-7. PubMed ID: 18245539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.